NASDAQ:XAIR

Beyond Air Stock Forecast, Price & News

$8.00

-0.21 (-2.56 %)

(As of 07/23/2021 12:00 AM ET)

Add

Compare

Today's Range

$7.89

▼

$8.19

50-Day Range

$4.72

▼

$8.40

52-Week Range

$4.62

▼

$9.30

Volume283,639 shs

Average Volume651,276 shs

Market Capitalization$175.20 million

P/E RatioN/A

Dividend YieldN/A

Beta-0.53

30 days | 90 days | 365 days | Advanced Chart

Receive XAIR News and Ratings via Email

Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter.

About Beyond Air

Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Beyond Air Sees Unusually High Options Volume (NASDAQ:XAIR)
July 21, 2021 | americanbankingnews.com

Need To Know: Beyond Air, Inc. (NASDAQ:XAIR) Insiders Have Been Buying Shares
July 21, 2021 | nasdaq.com

Beyond Air® Schedules First Fiscal Quarter 2022 Financial Results Conference Call and Webcast
July 20, 2021 | finance.yahoo.com

Short Interest in Beyond Air, Inc. (NASDAQ:XAIR) Declines By 29.2%
July 19, 2021 | americanbankingnews.com

Beyond Air, Inc. (NASDAQ:XAIR) Given Average Rating of "Buy" by Brokerages
July 18, 2021 | americanbankingnews.com

Insider Buying: Beyond Air, Inc. (NASDAQ:XAIR) CEO Purchases 25,000 Shares of Stock
July 15, 2021 | americanbankingnews.com

Beyond Air: Return On Capital Employed Insights
July 13, 2021 | benzinga.com

Beyond Air, Inc. (NASDAQ:XAIR) Expected to Announce Quarterly Sales of $650,000.00
July 11, 2021 | americanbankingnews.com

-$0.19 Earnings Per Share Expected for Beyond Air, Inc. (NASDAQ:XAIR) This Quarter
July 9, 2021 | americanbankingnews.com

Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021
July 8, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:XAIR
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.ait-pharm.com
Phone516-665-8200
Employees41
Year FoundedN/A

Sales & Book Value

Annual Sales$870,000.00
Price / Sales201.38
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.49 per share
Price / Book5.37

Profitability

EPS (Most Recent Fiscal Year)($1.27)
Net Income$-22,880,000.00
Net Margins-2,617.28%
Return on Equity-111.52%
Return on Assets-78.41%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares21,900,000
Market Cap$175.20 million
Next Earnings Date8/10/2021 (Confirmed)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.94 out of 5 stars

Medical Sector

105th out of 2,214 stocks

Surgical & Medical Instruments Industry

11th out of 181 stocks

4.5 Analyst's Opinion

Consensus Rating
Beyond Air has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $12.20, Beyond Air has a forecasted upside of 52.5% from its current price of $8.00.
Amount of Analyst Coverage
Beyond Air has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.9 Community Rank

Outperform Votes
Beyond Air has received 34 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Beyond Air has received 24 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Beyond Air has received 58.62% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Beyond Air and other stocks. Vote “Outperform” if you believe XAIR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe XAIR will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Beyond Air does not currently pay a dividend.
Dividend Growth
Beyond Air does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Beyond Air insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,881,380.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 14.70% of the stock of Beyond Air is held by insiders.
Percentage Held by Institutions
Only 20.82% of the stock of Beyond Air is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Beyond Air are expected to grow in the coming year, from ($0.97) to ($0.71) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Beyond Air is -6.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Beyond Air is -6.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Beyond Air has a P/B Ratio of 5.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Beyond Air (NASDAQ:XAIR) Frequently Asked Questions

Is Beyond Air a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Beyond Air stock.
View analyst ratings for Beyond Air or view top-rated stocks.

What stocks does MarketBeat like better than Beyond Air?

Wall Street analysts have given Beyond Air a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Beyond Air wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Beyond Air?

Beyond Air saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 2,640,000 shares, a decrease of 29.2% from the June 15th total of 3,730,000 shares. Based on an average trading volume of 462,900 shares, the days-to-cover ratio is presently 5.7 days. Currently, 14.6% of the shares of the stock are short sold.
View Beyond Air's Short Interest.

When is Beyond Air's next earnings date?

Beyond Air is scheduled to release its next quarterly earnings announcement on Tuesday, August 10th 2021.
View our earnings forecast for Beyond Air.

How can I listen to Beyond Air's earnings call?

Beyond Air will be holding an earnings conference call on Tuesday, August 10th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Beyond Air's earnings last quarter?

Beyond Air, Inc. (NASDAQ:XAIR) issued its earnings results on Wednesday, June, 9th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.31) by $0.07. The company earned $0.15 million during the quarter, compared to the consensus estimate of $0.38 million. Beyond Air had a negative net margin of 2,617.28% and a negative trailing twelve-month return on equity of 111.52%.
View Beyond Air's earnings history.

How has Beyond Air's stock been impacted by Coronavirus (COVID-19)?

Beyond Air's stock was trading at $5.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, XAIR stock has increased by 50.4% and is now trading at $8.00.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for XAIR?

5 Wall Street analysts have issued 1-year price objectives for Beyond Air's stock. Their forecasts range from $9.00 to $17.00. On average, they anticipate Beyond Air's stock price to reach $12.20 in the next twelve months. This suggests a possible upside of 52.5% from the stock's current price.
View analysts' price targets for Beyond Air or view top-rated stocks among Wall Street analysts.

Who are Beyond Air's key executives?

Beyond Air's management team includes the following people:

Mr. Steven Adam Lisi, CEO & Chairman (Age 50, Pay $450k)
Mr. Amir Avniel, Co-Founder, Pres, COO & Director (Age 47, Pay $400k)
Mr. Douglas J. Beck CPA, CPA, Chief Financial Officer (Age 60, Pay $250k)
Mr. Adam Newman, Chief Legal Officer & Gen. Counsel
Mr. Duncan Fatkin, Chief Commercial Officer
Ms. Maria Yonkoski, Head of Investor Relations
Ms. Rebecca Van Doren, Head of Sales
Ms. Kori-Ann Taylor, Head of Marketing
Dr. Giora Davidai M.D., Chief Medical Officer
Mr. Ali Ardakani, Sr. VP of Device & Bus. Devel.

Who are some of Beyond Air's key competitors?

Some companies that are related to Beyond Air include Invo Bioscience (IVOB), Intersect ENT (XENT), SeaSpine (SPNE), Vapotherm (VAPO), Anika Therapeutics (ANIK), NeuroPace (NPCE), Asensus Surgical (ASXC), Pulse Biosciences (PLSE), PAVmed (PAVM), AVITA Medical (RCEL), Soliton (SOLY), Acutus Medical (AFIB), UFP Technologies (UFPT), IRadimed (IRMD) and ClearPoint Neuro (CLPT).
View all of XAIR's competitors.

What other stocks do shareholders of Beyond Air own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH), General Motors (GM), Livongo Health (LVGO), Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI).

What is Beyond Air's stock symbol?

Beyond Air trades on the NASDAQ under the ticker symbol "XAIR."

How do I buy shares of Beyond Air?

Shares of XAIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Beyond Air's stock price today?

One share of XAIR stock can currently be purchased for approximately $8.00.

How much money does Beyond Air make?

Beyond Air has a market capitalization of $175.20 million and generates $870,000.00 in revenue each year. The company earns $-22,880,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis.

How many employees does Beyond Air have?

Beyond Air employs 41 workers across the globe.

What is Beyond Air's official website?

The official website for Beyond Air is www.ait-pharm.com.

Where are Beyond Air's headquarters?

Beyond Air is headquartered at 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530.

How can I contact Beyond Air?

Beyond Air's mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The company can be reached via phone at 516-665-8200.

This page was last updated on 7/25/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here